Delivery Order SPE2DR25D2100-SPE2DR26FA1LV
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,111.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, awarded on January 6, 2026, is structured as a firm fixed-price delivery order with an ultimate completion date of January 28, 2026. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This award was made on a non-set-aside, competitive basis and represents a task...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,274.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This competitively awarded, non-set-aside contract is structured as a firm fixed-price delivery order with an ultimate completion date of February 17, 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $10,321.10 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on August 12, 2025, carries a firm fixed price structure with an ultimate completion date of September 3, 2025. This is a non-set-aside, competitively awarded delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at...
- The Defense Logistics Agency awarded a delivery order valued at $6,370.50 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This firm fixed-price delivery order was competitively awarded without a set-aside designation and is scheduled for completion by February 5, 2026. The products will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This award represents a task order against AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,367.32 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, competitively awarded contract with a place of performance in Conshohocken, Pennsylvania, and an ultimate completion date of January 29, 2026. The contract carries no set-aside designation, indicating open competition among qualified vendors. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,019.65 to AmerisourceBergen Drug Corp for the provision of Varivax vaccine with diluents. The contract, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, carries firm fixed pricing and represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,053.01 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on July 25, 2025, with an ultimate completion date of August 15, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $11,630.70 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, effective January 7, 2026, with an ultimate completion date of January 29, 2026, represents a firm fixed-price procurement with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,111.33 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract, issued on December 31, 2025, is structured as a firm fixed-price delivery order with an ultimate completion date of January 23, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This award was...
- The Defense Logistics Agency awarded a delivery order valued at $3,059.07 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. The contract was competitively awarded without a set-aside designation and carries a firm fixed price structure, with an ultimate completion date of December 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- SPE2DR25D2100Indefinite Delivery Contract
- SPE2DR25D2100-SPE2DR26FA1LVDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,822.30 to AmerisourceBergen Drug Corp for the supply of Varivax vaccine with diluents. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of February 18, 2026. The products will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen's corporate office is headquartered. This delivery order is issued under a larger indefinite delivery contract vehicle with DLA Troop Support Medical, which carries a potential value of $999,999,999 and runs through December 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as AmerisourceBergen), is a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs for military and veteran healthcare systems. The company was competitively selected for this award and routinely supplies vaccines, pharmaceuticals, medical devices, and specialized healthcare commodities across multiple therapeutic domains to the DLA and other federal agencies. This contract supports the medical supply chain requirements for military treatment facilities and government healthcare systems through the pharmaceutical prime vendor program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 1/26/26 |